Sonolisib CAS No.502632-66-8
Sonolisib CAS No.502632-66-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1225 | 5mg | 350.00 | + Add to cart |
|
| R-R-1225 | 10mg | 570.00 | + Add to cart |
|
|
|
||||
Product description
Sonolisib (PX-866)/CAS No.502632-66-8, an improved Wortmannin analogue, is an oral, irreversible, and pan-isoform inhibitor of PI3K (IC50=0.1 nM (p110α), 1.0 nM (p120γ), 2.9 nM (p110δ)). Antitumor activity.
| Appearance | N/A |
|---|---|
| Molecular Weight | 525.59 |
| Purity | >90% |
| CAS | 502632-66-8 |
| Formula | C29H35NO8 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Sonolisib CAS No.502632-66-8
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


